BCRABL Initial Screen
Description:
The BCR-ABL fusion gene is detected in 95% of CML cases, in 25-30% of adult ALL and 2-5% of childhood ALL .The BCRABL fusion transcript is the result of the reciprocal translocation between the long arms of chromosome 9 and chromosome 22 - [t(9;22)]. The breakpoint in the ABL-gene is generally 5’ of the exon a2. The major breakpoint region (M-bcr) identified in the BCR gene, lies within a 5.8kb large fragment, spanning exons b1 to b5. The most common M-bcr fusion transcripts are b3a2 and b2a2 or a mixture of both, although some other less common transcripts are also identified, ie b2a3, b3a3 .
Reference range:
PB/BM
Department:
Location:
Sample type and Volume required:
EDTA
Turnaround time:
2 weeks
Special sample instructions:
Samples should reach the laboratory within 24 hours of being taken
Storage and transport:
Room temperature, Samples in EDTA preservative
Contacts:
Molecular Oncology Unit at Guy's
0207 188 1716
viapath.OncologyDutyScientist@nhs.net
Genetics Department
Southwark Wing - 4th Floor
Guy's Hospital
Great Maze Pond
London SE1 9RT
Southwark Wing - 4th Floor
Guy's Hospital
Great Maze Pond
London SE1 9RT
Laboratory:
Last updated: 07/08/2015